Showing results (31-40 of 778) with videos related to
Sort By:
Pageof 78
Therapeutic Drug Monitoring|August 26, 1998
Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approachA J McLachlan, S E TettStatistics in Medicine|March 26, 2003
An EM-based semi-parametric mixture model approach to the regression analysis of competing-risks dataS K Ng, G J McLachlanAntimicrobial Agents and Chemotherapy|June 19, 2002
Physiologically based pharmacokinetic model for terbinafine in rats and humansMahboubeh Hosseini-Yeganeh, Andrew J McLachlanThe Journal of Pharmacy and Pharmacology|April 5, 2012
Investigating paracetamol pharmacokinetics using venous and capillary blood and saliva samplingAnneliese M Rittau, Andrew J McLachlanThe Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 13, 2011
Drug metabolism in older people--a key consideration in achieving optimal outcomes with medicinesAndrew J McLachlan, Lisa G PontBritish Journal of Clinical Pharmacology|April 1, 1996
Pharmacokinetics of fluconazole in people with HIV infection: a population analysisA J McLachlan, S E TettArtificial Intelligence in Medicine|July 17, 2007
Extension of mixture-of-experts networks for binary classification of hierarchical dataShu-Kay Ng, Geoffrey J McLachlanInternational Journal of Antimicrobial Agents|August 10, 2014
Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicityMichael J Dolton, Andrew J McLachlanPharmacological Research|December 25, 2013
The pharmacogenomics of statinsIngrid C Gelissen, Andrew J McLachlanPageof 78